Acutus Medical, Inc. (AFIB) is a Medical - Devices company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is AFIB = $2 (+499900% upside).
Financials: revenue is $20M, +40%/yr average growth. Net income is $10M (loss), growing at +16.7%/yr. Net profit margin is -47.4% (negative). Gross margin is 5% (+95.7 pp trend).
Balance sheet: total debt is $36M with negative equity of -$12M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 2.06 (strong liquidity). Debt-to-assets is 124.8%. Total assets: $29M.
Analyst outlook: 1 / 6 analysts rate AFIB as buy (17%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 90/100 (Pass), Past 0/100 (Fail), Health 50/100 (Partial), Moat 15/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).
